26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

IX. Selected Neuromuscular Disorders <strong>of</strong> <strong>Domestic</strong> <strong>Animals</strong><br />

475<br />

include the following presentations: acute quadriplegia,<br />

degrees <strong>of</strong> exercise-related weakness, gait abnormalities,<br />

no apparent limb muscle weakness with dysphagia,<br />

or regurgitation associated with a megaesophagus. There<br />

appears to be a bimodal distribution in the onset <strong>of</strong> this disease<br />

in dogs (early and late onset). Dogs are rarely affected<br />

before 1 year <strong>of</strong> age and peak frequencies were found at<br />

3 and 10 years <strong>of</strong> age; the prevalence did not appear to be<br />

gender related ( Dewey et al. , 1997 ; Shelton et al. , 1988 ).<br />

Frequently, overt signs may be limited to esophageal dysfunction.<br />

In a study <strong>of</strong> 152 dogs afflicted with idiopathic<br />

megaesophagus, 40 to 57 dogs (26% to 38%) had MG<br />

( Shelton et al. , 1990 ).<br />

A definitive diagnosis <strong>of</strong> MG is provided by detection<br />

<strong>of</strong> circulating antibodies to the AChR. Additional diagnostic<br />

tests that provide for a presumptive diagnosis include clinical,<br />

pharmacological, electrodiagnostic, and immunocytochemical<br />

methods <strong>of</strong> evaluation ( Dewey et al. , 1997 ; Shelton,<br />

2002 ). When clinical signs permit the objective assessment<br />

<strong>of</strong> strength, pharmacological testing can be employed<br />

through the intravenous administration <strong>of</strong> 1 to 10 mg <strong>of</strong> edrophonium<br />

chloride, an ultra-short-acting anticholinesterase<br />

agent. Improved strength with edrophonium provides a presumptive<br />

diagnosis <strong>of</strong> MG. A presumptive diagnosis <strong>of</strong> MG<br />

is also suggested when the application <strong>of</strong> low-frequency (2 to<br />

10 Hz), repetitive nerve stimulation results in the reduced<br />

amplitude <strong>of</strong> the first few evoked compound MAPs (decrementing<br />

response). Immunocytochemical procedures provide<br />

presumptive tests for MG. In muscle biopsies <strong>of</strong> human and<br />

canine MG patients that contain neuromuscular junctions, it<br />

is possible to localize the IgG bound to the PSM using the<br />

immunoreagent ( Engel and Hohfield, 2004 ; Pflugfelder et al. ,<br />

1981 ). A more specific diagnosis can be established by measuring<br />

acetylcholine receptor antibody titer in serum samples<br />

from affected animals ( Dewey et al. , 1997 ; Shelton, 2002 ).<br />

b . Congenital Myasthenia Gravis<br />

Congenital MG is a developmental disorder <strong>of</strong> humans and<br />

dogs ( Dickinson et al. , 2005 ; Engel et al. , 2004 ; Shelton,<br />

2002 ). In the dog, the synthesis <strong>of</strong> AChRs appears to be<br />

normal, and degradation does not appear to be accelerated.<br />

The reduced AChR density is believed to be due to a low<br />

insertion rate <strong>of</strong> AChRs into the PSM ( Engel et al. , 2004 ).<br />

In humans, several congenital myasthenic syndromes are<br />

recognized, which result from a number <strong>of</strong> inherited defects<br />

that may be presynaptic (7% <strong>of</strong> cases), synaptic basal lamina-associated<br />

(14%), or postsynaptic (79%) defects ( Engel<br />

et al. , 2004 ). Because congenital MG is not immune mediated,<br />

the immunodiagnostic tests used in acquired MG are<br />

<strong>of</strong> no value in establishing the diagnosis <strong>of</strong> congenital MG.<br />

2 . Sodium Ion Channels and Periodic Paralysis<br />

Hyperkalemic periodic paralysis (HyPP) is a dominantly<br />

inherited disorder <strong>of</strong> muscle in quarter horses, American<br />

paint horses, Appaloosas, and quarter horse crossbred animals<br />

that causes episodes <strong>of</strong> tremors, myotonia, weakness,<br />

or paralysis in association with elevated serum potassium<br />

( Naylor, 1997 ; Spier et al. , 1990 ). Weakness or paralysis<br />

can be induced by the ingestion <strong>of</strong> potassium. HyPP<br />

is caused by a single base pair sequence defect within the<br />

gene encoding the voltage-dependent equine skeletal muscle<br />

sodium channel α-subunit (Rudolph et al. , 1992 ). The point<br />

mutation produces a Phe to Leu substitution in the transmembrane<br />

domain IVS3. Patients are usually heterozygous<br />

and express both normal and mutant α-subunits, although<br />

homozygous HyPP horses have been identified. The primary<br />

physiological defect in the mutant sodium channels is<br />

impaired inactivation ( Cannon et al. , 1995 ). This results in<br />

a resting membrane potential that is closer to firing than in<br />

normal horses. Sodium channels are normally briefly activated<br />

during the initial phase <strong>of</strong> the muscle action potential.<br />

The HyPP mutation results in a failure <strong>of</strong> a subpopulation <strong>of</strong><br />

sodium channels to inactivate when serum potassium concentrations<br />

are increased. As a result, an excessive inward<br />

flux <strong>of</strong> sodium and outward flux <strong>of</strong> potassium ensues, resulting<br />

in persistent depolarization <strong>of</strong> muscle cells and temporary<br />

weakness. It appears likely that the clinical variability<br />

and severity <strong>of</strong> signs are associated with the ratio <strong>of</strong> mutantto-normal<br />

sodium ion channels expressed in the skeletal<br />

muscles <strong>of</strong> heterozygous horses ( Zhou et al. , 1994 ). This disorder<br />

in horses is similar to HyPP in humans in which there<br />

are also a number <strong>of</strong> mutations involving the gene encoding<br />

the sodium ion channel α-subunit (Lehmann-Horn et al. ,<br />

2002 ). A definitive diagnosis is possible by base-pair analysis<br />

<strong>of</strong> the DNA sequence responsible for encoding <strong>of</strong> the<br />

α -subunit ( Rudolph et al. , 1992 ).<br />

3 . Chloride Ion Channels and Myotonia<br />

Myotonia is a clinical sign in which uncontrolled, prolonged,<br />

and painless contraction <strong>of</strong> skeletal muscles occurs. The<br />

condition is due to hyperexcitability <strong>of</strong> the sarcolemma and<br />

the abnormal production <strong>of</strong> repetitive depolarizations <strong>of</strong> the<br />

sarcolemma followed by delayed repolarization and relaxation.<br />

Affected patients exhibit varying degrees <strong>of</strong> muscle<br />

stiffness with the onset <strong>of</strong> exercise. The stiffness will <strong>of</strong>ten<br />

subside with continued exercise or repeated movements and<br />

is not aggravated by cold. Muscles may be grossly hypertrophied<br />

with well-defined muscle groups. Percussion <strong>of</strong> muscles<br />

results in local contractions that create dimpling <strong>of</strong> the<br />

surface overlying the contracting muscles.<br />

Two principal myotonic disorders occur in humans: (1)<br />

myotonia congenita and (2) myotonic dystrophy ( Harper<br />

and Monckton, 2004 ). Myotonia congenita is a nonprogressive<br />

childhood disorder in which there is a diminished<br />

chloride conductance across the sarcolemma caused<br />

by mutations <strong>of</strong> the skeletal muscle chloride ion channel<br />

( Heine et al. , 1994 ). A similar form <strong>of</strong> myotonia congenita<br />

occurs as a recessive trait in miniature schnauzers

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!